Archivio di Ortopedia e Reumatologia

, Volume 119, Issue 3, pp 28–30

L’aderenza alle terapie per l’osteoporosi: l’esempio dei bisfosfonati

  • S. Casari
  • L. Sinigaglia
Articolo su Invito

DOI: 10.1007/s10261-009-0012-0

Cite this article as:
Casari, S. & Sinigaglia, L. Arch Ortop Reumatol (2009) 119: 28. doi:10.1007/s10261-009-0012-0

Adherence to osteoporosis therapy: the example of bisphosphonates


Bisphosphonates are the most potent and effective inhibitors of bone resorption in clinical use, with good efficacy and tolerability in reducing fracture risk, in increasing bone mineral density and in reducing biochemical markers of bone turnover. Clinical trials indicate that bisphosphonates can reduce the incidence of fractures related to postmenopausal osteoporosis but adherence to bisphosphonate therapy remains suboptimal. Long-term adherence with bisphosphonates is required for optimal and sustained therapeutic benefits in postmenopausal osteoporosis. Simplifying dosing by reducing the frequency and/or number of administrations is an often-used strategy for enhancing adherence, especially with new compounds with high anti-resorptive potency and favourable bone-binding properties

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • S. Casari
    • 1
  • L. Sinigaglia
    • 1
  1. 1.U.O.C.Day Hospital di ReumatologiaIstituto Ortopedico G.PiniMilanoItaly

Personalised recommendations